GraniteShares ETF Trust - GraniteShares YieldBOOST CRCL ETF (CRY)
| Assets | n/a |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Shares Out | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 50 |
| Open | 24.96 |
| Previous Close | 17.88 |
| Day's Range | 24.96 - 24.96 |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta | n/a |
| Holdings | n/a |
| Inception Date | n/a |
About CRY
Fund Home PageGraniteShares ETF Trust - GraniteShares YieldBOOST CRCL ETF is an exchange-traded fund launched by GraniteShares Inc. The fund is managed by GraniteShares Advisors LLC. It invests in public equity markets. The fund invests through derivatives in stocks of companies operating across software and services sectors. It uses derivatives such as options to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalizations. GraniteShares ETF Trust - GraniteShares YieldBOOST CRCL ETF is domiciled in the United States.
News
CryoLife Announces Corporate Rebranding and Changes Name to Artivion
ATLANTA, Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself ...
A Trio of Low Price-Sales Ratio Stocks
Value investors may find the following stocks to be attractive opportunities, as they have low price-sales ratios compared to the S&P 500 and good profitability.
CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum
ATLANTA, Nov. 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will host one-on-...
Recap: Cryolife Q3 Earnings
Cryolife (NYSE:CRY) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM. Here's what investors need to know about the announcement.
CryoLife Reports Third Quarter 2021 Financial Results
ATLANTA, Nov. 4, 2021 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $72.2 million in the third quarter 2021 versus $65.1 million in the third quarter of 2020...
CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results
ATLANTA, Oct. 20, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021 financial results w...
Anthony Semedo Joins CryoLife Board of Directors
ATLANTA, Sept. 22, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo t...
CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
ATLANTA, Aug. 31, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Mo...
CryoLife to Participate in Upcoming Virtual Investor Conferences
ATLANTA, Aug. 2, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming vir...
Cryolife: Q2 Earnings Insights
Shares of Cryolife (NYSE:CRY) rose 2.9% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 700.00% year over year to $0.12, which beat the estimat...
CryoLife Reports Second Quarter 2021 Financial Results
ATLANTA, July 29, 2021 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $76.1 million in the second quarter 2021 versus $53.8 million in the second quarter of ...
CryoLife Announces Sale of PerClot to Baxter
ATLANTA, July 29, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerCl...
Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced its Baxter Healthcare Corporation subsidiary has completed the acquisition ...
CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
ATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results ...
CryoLife to Participate in the UBS Global Healthcare Virtual Conference
ATLANTA, May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS...
Cryolife: Q1 Earnings Insights
Shares of Cryolife (NYSE:CRY) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 137.50% year over year to $0.03, which beat the estimat...
CryoLife Reports First Quarter 2021 Financial Results
ATLANTA, April 29, 2021 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $71.1 million in the first quarter 2021 versus $66.4 million in the first quarter of 20...
CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results
ATLANTA, April 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021 financial results ...
CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference
ATLANTA, April 7, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 20...
CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference
ATLANTA, March 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Op...
Recap: Cryolife Q4 Earnings
Shares of Cryolife (NYSE:CRY) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 81.82% over the past year to $0.20, which beat the esti...
CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020
ATLANTA, Nov. 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors a...
CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results
ATLANTA, Oct. 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter financial results w...
CryoLife to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
ATLANTA, Sept. 8, 2020 /PRNewswire/ -- CryoLife, Inc.
CryoLife Acquires Ascyrus Medical
ATLANTA, Sept. 2, 2020 /PRNewswire/ -- CryoLife, Inc.